Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
US10874661B2 · kind B2 · utility
2Cited by
49References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 31, 2018 |
| Grant date | Dec 29, 2020 |
| Priority date | — |
| Expiry date | Jul 31, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided pharmaceutical compositions for the treatment of e.g. opioid dependency comprising microparticles of a pharmacologically-effective amount of buprenorphine, or a pharmaceutically-acceptable salt thereof, in associative admixture with particles comprising a weak acid, or particles comprising weakly-acidic buffer forming materials. The composition may further comprise a disintegrant and/or particles of a pharmacologically-effective amount of naloxone, or a pharmaceutically-acceptable salt thereof. The compositions are useful in the treatment of opioid dependency/addiction and/or pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.